glp-1 vs bariatric surgery Metabolic vs. Receptor Agonists for Obesity Management Bariatric Surgery Yields 5x More

The evidence base is robust, effects are predictable, and medical supervision protects safety

We recommend starting with a half-dose of any new supplement for the first week to see how your system responds

When combining GLP-1 receptor agonists with insulin or sulfonylureas, the chance of experiencing hypoglycemia (low blood sugar) goes up

doi: 10.1152/ajprenal.00394.2015 101 ThomsonSCKashkouliASinghP

The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive

Different GLP-1 therapies could be tailored to patients individual metabolic needs A new analysis shows that GLP-1 therapies can deliver distinct benefits to different heart and metabolic health needs beyond just weight loss